Hem

Press release from Companies

Publicerat: 2021-09-14 08:00:00

CS MEDICA A/S: First day of trading in CS MEDICA’s shares and warrants at Spotlight Stock Market

Today is the first day of trading in CS MEDICA A/S’s ("CS MEDICA" or the "Company")  shares and warrants. CS MEDICA’s shares are traded under the ticker "CSMED" with ISIN DK0061668225 and the Company’s warrants are traded under the ticker "CSMED TO 1" with ISIN DK0061668308.

Prior to listing at Spotlight Stock Market, CS MEDICA conducted a successful IPO which was subscribed to a total of approx. 158 percent. The capitalization provided the Company with initially approx. DKK 22.3 million (before issue costs, offset of bridge loan financing and compensation).

The number of shares in the Company amounts to 10,902,000 and the share capital is DKK 708,630 after the IPO. In addition, there are a total of 1,160,800 outstanding warrants of series TO 1. The exercise period of the warrants is planned to take place between August 18th - September 1st, 2022. Each warrant entitles the holder to subscribe for one new share in the Company at a price of DKK 9.30 per share. Upon full exercise of all attached warrants, the Company will receive approx. DKK 10.8 million before issue costs.

Advisors
CS MEDICA has in connection with the issue of units appointed Sedermera Fondkommission as financial advisor, Markets & Corporate Law Nordic AB as the legal advisor, Nordic Issuing as issuing agent, and Nordnet Bank AB as selling agent.

For more information about the capitalization, please contact:
Sedermera Fondkommission

Phone: +46 (0) 40 615 14 10
Email: info@sedermera.se

For more information about CS MEDICA, please contact:
Lone Henriksen, CEO
Phone: + (45) 71 20 30 47
Email: lh@galaxapharma.com
Website: https://www.cs-medica.com/

CS MEDICA A/S is a Danish medico cannabis company founded in 2011. CS MEDICA is committed to developing, manufacturing, and commercializing over-the-counter (OTC) medical device products containing cannabinoids. The Company runs its business through the two fully-owned subsidiaries, Galaxa Pharma A/S (distributor and representative of foreign manufacturers in the Nordic, registered medical device product distributor) and CanNordic A/S (Medical device developer and seller (BtB), registered medical device product  manufacturer). CS MEDICA distributes products across the European borders and is headquartered in Copenhagen, Denmark.

Läs mer hos Cision
Läs mer om CS MEDICA A/S

Prenumeration